Even though there is a general agreement about an increase in EZH2 expression in CRC compared to normal tissue, its prognostic value is controversially discussed (Benard et al. 2014; Fluge et al. 2009; Liu et al. 2015; He et al. 2014). This evidence concerns the gene EZH2 and colorectal carcinoma.